Psychiatry is a field of contradictions. On one hand, it saves lives; on the other, it sometimes traps people in diagnostic purgatory. Some psychiatrists are conservative, prescribing as little as possible; others believe in a more-the-merrier approach to pharmacology. Some are pioneers, pushing boundaries with emerging treatments; others are still prescribing as if it were 1985.

Which brings us to Emma, a 26- year-old woman diagnosed with bipolar disorder at 16 and medicated accordingly. Fast-forward a decade, and she’s still on almost the same regimen—a cocktail of lithium, Seroquel, benzodiazepines, and antidepressants. Instead of finding stability, she’s now battling severe insomnia, obsessive-compulsive symptoms, unresolved trauma, and what appears to be undiagnosed neurodivergence.

But here’s the kicker: was it ever bipolar disorder in the first place?

Diagnosis: Science or Educated Guesswork?

Psychiatry likes to present itself as methodical, evidence-based, and precise. But as Karl Jaspers, one of the fathers of modern psychiatric thinking, noted: diagnosis in psychiatry is far more subjective than in any other medical field. Two psychiatrists can look at the same patient and arrive at entirely different conclusions. Emma’s original psychiatrist—likely overworked and stretched thin—labeled it bipolar disorder and moved on.

But now? A therapist sees strong ASD traits and wonders if ADHD has been overlooked. Meanwhile, her PCOS-driven hormonal imbalances remain largely ignored, even though Robert Sapolsky, the Stanford neuroscientist, has long emphasized the intricate relationship between hormones and mental health.

So here’s a brutal question:
When was the last time Emma received a full diagnostic reassessment?

Answer: Never.

The Medication Maze: Treatment or Entrapment?

Let’s talk about psychiatry’s favorite tool: medication. In many cases, it’s life-changing. But what happens when the prescription pad becomes the entire treatment plan? Emma was started on lithium at 17—and she’s still on it, even though there’s no clear evidence she’s ever had a classic manic episode.

And the rest?
• Seroquel—adds weight gain and grogginess, but restorative sleep? Not so much.
• Sertraline—helps with OCD, but at what cost to everything else?
• Clonidine—six times daily. That’s not a typo.
• Benzodiazepines (Temazepam & Diazepam)—short-term solutions that became permanent crutches.
• Depo-Provera injections—hormonal impacts, barely explored.

At what point do we ask: how much of her distress is the original illness—and how much is now iatrogenic? As Allen Frances—the lead editor of the DSM-IV—once said, “There is no definition of a mental disorder. It’s bullshit. I mean, you just can’t define it.”

The system says: “Trust the diagnosis.”
But reality says: “Maybe we got it wrong.”

Reassessing the Goal: Symptom Suppression or Functional Recovery?

What should treatment aim for? If quality of life and functional capacity are the targets, Emma is nowhere close. She struggles to work 1-2 days a week, stuck in survival mode. Every attempt to taper medication has been rushed and destabilizing.

Which leads to another uncomfortable question: What’s the exit strategy?

The US has seen controlled ketamine therapy gaining traction—not as a trendy shortcut, but as a potential nervous system reset under strict conditions. As Stanford psychiatrist Dr. Nolan Williams points out, ketamine can sometimes “unlock” patients from entrenched medication cycles. But will mainstream psychiatry embrace new approaches—or just keep handing out more scripts?

Where Is Psychiatry Heading?

Here’s the big-picture dilemma:
Psychiatric paradigms change every 35-50 years. Fifty years ago, homosexuality was in the DSM as a disorder. Thirty years ago, Prozac was the miracle cure. What will the next 40 years bring in an increasingly commercialized healthcare system?

Telehealth is reshaping psychiatry, but is progress possible in a Fee-For-Service model where efficiency is often prioritized over accuracy? Will we see more psychiatrists committed to deep diagnostic work—or will the pressure to move fast mean more misdiagnoses and prolonged medication cycles?

Final Thought: The People Psychiatry Struggles to Treat

Emma is not a one-off case. She represents thousands of patients who don’t fit neatly into a DSM box. The challenge for psychiatrists, psychologists, psychotherapists, and GPs is this:
• Are we diagnosing what we see—or what we expect to see?
• Are we treating patients toward recovery—or just keeping symptoms at bay?
• How do we prevent people like Emma from falling through the cracks?

The best psychiatrists—whether Freud, Jaspers, Sapolsky, or Frances—have always asked uncomfortable questions. Maybe it’s time more of us did the same.

So, if Emma walked into your office tomorrow—what would you do differently?

Paul Alexander Wolf